Jason Alger Health Catalyst, Inc. (HCAT) insider trading activity

Jason Alger is Chief Financial Officer of Health Catalyst, Inc.. Currently has a direct ownership of 267,033 shares of HCAT, which is worth approximately $833,142. The most recent transaction as insider was on Sep 06, 2022, when has been sold 262 shares (Common Stock) at a price of $11.28 per share, resulting in proceeds of $2,955. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 267K

0.97% 3M change

134.02% 12M change

Total Value Held $833,142

Jason Alger Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 06 2022	SELL Open market or private sale	$2,955 $11.28 p/Share	262 Reduced 0.71%	36,522 Common Stock
Sep 01 2022	SELL Payment of exercise price or tax liability	$6,583 $11.61 p/Share	567 Reduced 1.52%	36,784 Common Stock
Jun 06 2022	SELL Open market or private sale	$3,902 $14.95 p/Share	261 Reduced 0.69%	37,351 Common Stock
Jun 01 2022	SELL Payment of exercise price or tax liability	$8,278 $14.6 p/Share	567 Reduced 1.49%	37,612 Common Stock
Mar 07 2022	SELL Open market or private sale	$11,590 $25.14 p/Share	461 Reduced 1.19%	38,179 Common Stock
Mar 02 2022	SELL Payment of exercise price or tax liability	$4,190 $26.69 p/Share	157 Reduced 0.4%	38,640 Common Stock
Mar 01 2022	SELL Payment of exercise price or tax liability	$25,618 $26.63 p/Share	962 Reduced 2.52%	37,246 Common Stock
Mar 01 2022	BUY Grant, award, or other acquisition	-	1,551 Added 3.84%	38,797 Common Stock
Feb 24 2022	BUY Grant, award, or other acquisition	-	25,000 Added 39.55%	38,208 Common Stock
Dec 06 2021	SELL Open market or private sale	$25,007 $38.83 p/Share	644 Reduced 4.65%	13,208 Common Stock
Dec 02 2021	SELL Payment of exercise price or tax liability	$61,247 $41.95 p/Share	1,460 Reduced 9.54%	13,852 Common Stock
Sep 03 2021	SELL Open market or private sale	$35,358 $54.23 p/Share	652 Reduced 4.08%	15,312 Common Stock
Sep 01 2021	SELL Payment of exercise price or tax liability	$15,510 $54.23 p/Share	286 Reduced 1.76%	15,964 Common Stock
Jun 03 2021	SELL Open market or private sale	$35,079 $52.75 p/Share	665 Reduced 3.93%	16,250 Common Stock
Jun 01 2021	SELL Payment of exercise price or tax liability	$14,655 $53.88 p/Share	272 Reduced 1.58%	16,915 Common Stock
Apr 13 2021	SELL Open market or private sale	$315,491 $50.07 p/Share	6,301 Reduced 26.83%	17,187 Common Stock
Mar 04 2021	SELL Open market or private sale	$28,294 $47.0 p/Share	602 Reduced 2.5%	23,488 Common Stock
Mar 01 2021	SELL Payment of exercise price or tax liability	$16,504 $49.12 p/Share	336 Reduced 1.38%	24,090 Common Stock
Feb 18 2021	BUY Grant, award, or other acquisition	-	15,000 Added 38.05%	24,426 Common Stock
Jan 14 2021	BUY Exercise of conversion of derivative security	$67,610 $10.73 p/Share	6,301 Added 40.06%	9,426 Common Stock

Jason Alger

Chief Financial Officer

South Jordan, UT

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HCAT shares.

Notify only if

Value

Insider Trading

Get notified when an Health Catalyst, Inc. insider buys or sells HCAT shares.

Notify only if

Operation

Value

Type

News

Receive news related to Health Catalyst, Inc.

Track Activities on HCAT

Account